SAN ANTONIO, July 27, 2018 /CNW/ - Nerium Biotechnology, Inc. ("the "Company") announced today that all of its disputes with Nerium International, ...
News
- Nerium Biotechnology Settles All Disputes with Nerium International and Other Parties
- Merck beats views on sales jumps for cancer drugs, vaccines
... Lynparza for ovarian cancer and Lenvima for thyroid cancer. And the company acquired Viralytics Ltd., an Australian biotech company developing ...
- Seattle Genetics: 2Q Earnings Snapshot
The biotechnology company posted revenue of $170.2 million in the period, also exceeding Street forecasts. Six analysts surveyed by Zacks expected ...
- Amgen: 2Q Earnings Snapshot
The world's largest biotech drugmaker posted revenue of $6.06 billion in the period, also exceeding Street forecasts. Eight analysts surveyed by Zacks ...
- Why Are Only 4 Percent of Cannabis Businesses Owned By African Americans?
Take Shanel Lindsay, the founder of Ardent Cannabis, a Boston-based biotech and medical cannabis company that specializes in the development of ...